Literature DB >> 23480179

Protecting against plague: towards a next-generation vaccine.

E D Williamson1, P C F Oyston.   

Abstract

The causative organism of plague is the bacterium Yersinia pestis. Advances in understanding the complex pathogenesis of plague infection have led to the identification of the F1- and V-antigens as key components of a next-generation vaccine for plague, which have the potential to be effective against all forms of the disease. Here we review the roles of F1- and V-antigens in the context of the range of virulence mechanisms deployed by Y. pestis, in order to develop a greater understanding of the protective immune responses required to protect against plague.
© 2012 Crown copyright. This article is published with the permission of the Controller of HMSO and the Queen´s Printer for Scotland.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480179      PMCID: PMC3719925          DOI: 10.1111/cei.12044

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  96 in total

Review 1.  Molecular and physiological insights into plague transmission, virulence and etiology.

Authors:  Dongsheng Zhou; Yanping Han; Ruifu Yang
Journal:  Microbes Infect       Date:  2005-08-10       Impact factor: 2.700

2.  Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice.

Authors:  G E Benner; G P Andrews; W R Byrne; S D Strachan; A K Sample; D G Heath; A M Friedlander
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  The Pla surface protease/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells.

Authors:  K Lähteenmäki; M Kukkonen; T K Korhonen
Journal:  FEBS Lett       Date:  2001-08-24       Impact factor: 4.124

4.  Pneumonic plague in an untreated plague-vaccinated individual.

Authors:  R J Cohen; J L Stockard
Journal:  JAMA       Date:  1967-10-23       Impact factor: 56.272

5.  Plague in Guinea pigs and its prevention by subunit vaccines.

Authors:  Lauriane E Quenee; Nancy Ciletti; Bryan Berube; Thomas Krausz; Derek Elli; Timothy Hermanas; Olaf Schneewind
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

Review 6.  The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.

Authors:  G R Cornelis
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

7.  An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Authors:  Sue Stacy; Amanda Pasquali; Valerie L Sexton; Angelene M Cantwell; Ellen Kraig; Peter H Dube
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  pH6 antigen of Yersinia pestis interacts with plasma lipoproteins and cell membranes.

Authors:  Elena Makoveichuk; Peter Cherepanov; Susanne Lundberg; Ake Forsberg; Gunilla Olivecrona
Journal:  J Lipid Res       Date:  2002-11-16       Impact factor: 5.922

9.  Transit through the flea vector induces a pretransmission innate immunity resistance phenotype in Yersinia pestis.

Authors:  Viveka Vadyvaloo; Clayton Jarrett; Daniel E Sturdevant; Florent Sebbane; B Joseph Hinnebusch
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

10.  Evaluation of the role of the Yersinia pestis plasminogen activator and other plasmid-encoded factors in temperature-dependent blockage of the flea.

Authors:  B J Hinnebusch; E R Fischer; T G Schwan
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

View more
  22 in total

1.  Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.

Authors:  Paul M Arnaboldi; Mariya Sambir; Christina D'Arco; Lauren A Peters; Jos F M L Seegers; Lloyd Mayer; Alison A McCormick; Raymond J Dattwyler
Journal:  Vaccine       Date:  2016-10-13       Impact factor: 3.641

2.  Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial.

Authors:  Kai Chu; Jialei Hu; Fanyue Meng; Jingxin Li; Li Luo; Jianjun Xu; Zhonghang Yuan; Zhiyong Li; Wangeng Chen; Lei Jiao; Yali Chang; Bingxiang Wang; Yuemei Hu
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

Review 3.  Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens.

Authors:  Yuchen Fan; James J Moon
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-04-01

4.  Structural snapshots along the reaction pathway of Yersinia pestis RipA, a putative butyryl-CoA transferase.

Authors:  Rodrigo Torres; Benson Lan; Yama Latif; Nicholas Chim; Celia W Goulding
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-03-20

Review 5.  Rational considerations about development of live attenuated Yersinia pestis vaccines.

Authors:  Wei Sun; Roy Curtiss
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

Review 6.  Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.

Authors:  Shujing Wang; Huiqin Liu; Xinyi Zhang; Feng Qian
Journal:  Protein Cell       Date:  2015-05-06       Impact factor: 14.870

7.  YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected].

Authors:  Ayelet Zauberman; Yehuda Flashner; Yinon Levy; Yaron Vagima; Avital Tidhar; Ofer Cohen; Erez Bar-Haim; David Gur; Moshe Aftalion; Gideon Halperin; Avigdor Shafferman; Emanuelle Mamroud
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  HSP70 domain II of Mycobacterium tuberculosis modulates immune response and protective potential of F1 and LcrV antigens of Yersinia pestis in a mouse model.

Authors:  Lalit Batra; Shailendra K Verma; Durgesh P Nagar; Nandita Saxena; Prachi Pathak; Satish C Pant; Urmil Tuteja
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

Review 9.  Plague vaccines: new developments in an ongoing search.

Authors:  Jason A Rosenzweig; Emily K Hendrix; Ashok K Chopra
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-18       Impact factor: 4.813

10.  Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague.

Authors:  Shih-shiung Huang; I-Hsun Li; Po-da Hong; Ming-kung Yeh
Journal:  Int J Nanomedicine       Date:  2014-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.